Abacavir (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Abacavir drug offered from Avera McKennan Hospital. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
NON-PROPRIETARY NAME: | Abacavir |
SUBSTANCE NAME: | ABACAVIR SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-02-29 |
END MARKETING DATE: | 0000-00-00 |
Abacavir HUMAN PRESCRIPTION DRUG Details:
Item Description | Abacavir from Avera McKennan Hospital |
LABELER NAME: | Avera McKennan Hospital |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 300(mg/1) |
START MARKETING DATE: | 2016-02-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69189-0547_bfe850bc-5e10-4e3b-80b5-94490099f202 |
PRODUCT NDC: | 69189-0547 |
APPLICATION NUMBER: | ANDA077844 |
Other ABACAVIR SULFATE Pharmaceutical Manufacturers / Labelers: